摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(22E,24S)-27-去甲-5alpha-麦角甾-22-烯-3beta-醇 | 58514-32-2

中文名称
(22E,24S)-27-去甲-5alpha-麦角甾-22-烯-3beta-醇
中文别名
——
英文名称
(22E,24S)-27-nor-24-methyl-5α-cholest-22-en-3β-ol
英文别名
(22E,24S)-27-norcholest-22-en-3β-ol;Patinosterol;(3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(E,2R,5S)-5-methylhept-3-en-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
(22E,24S)-27-去甲-5alpha-麦角甾-22-烯-3beta-醇化学式
CAS
58514-32-2
化学式
C27H46O
mdl
——
分子量
386.662
InChiKey
MQDWBAYFXRRHRX-BPTFOWNUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    470.9±14.0 °C(Predicted)
  • 密度:
    0.967±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    8.6
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    乙酸酐(22E,24S)-27-去甲-5alpha-麦角甾-22-烯-3beta-醇吡啶 作用下, 以16 mg的产率得到(22E,24S)-27-nor-24-methyl-5α-cholest-22-en-3β-ol acetate
    参考文献:
    名称:
    Stereoselective synthesis via Claisen rearrangements of the marine sterols occelasterol, patinosterol, and 22,23-dihydrooccelasterol
    摘要:
    DOI:
    10.1021/jo00133a036
  • 作为产物:
    描述:
    (22E,24S)-27-nor-3α,5-cyclo-6β-methoxy-24-methyl-5α-cholest-22-en-26-ol p-toluenesulfonate 在 lithium aluminium tetrahydride 、 、 aluminum isopropoxide 、 lithium对甲苯磺酸 作用下, 以 四氢呋喃1,4-二氧六环乙醚乙醇丙酮 为溶剂, 反应 19.5h, 生成 (22E,24S)-27-去甲-5alpha-麦角甾-22-烯-3beta-醇
    参考文献:
    名称:
    Stereoselective synthesis via Claisen rearrangements of the marine sterols occelasterol, patinosterol, and 22,23-dihydrooccelasterol
    摘要:
    DOI:
    10.1021/jo00133a036
点击查看最新优质反应信息

文献信息

  • Therapeutic properties of oils
    申请人:Ferrante Antonio
    公开号:US20050123479A1
    公开(公告)日:2005-06-09
    The present invention provides a novel scientific approach to determine whether a compound has anti-inflammatory activity. In particular, the novel assays allow the screening of compounds for the purposes of prophylactic and therapeutic use in treating or ameliorating the symptoms of T-cell, macrophage or neutrophil mediated diseases in mammals. In particular, the invention is based on the measurement of the capacity of a substance being an oil or fat, an alcoholic extract of an oil or fat, a biologically active component of an oil or a fat, or a preparation comprising an oil or fat, to suppress the activity of T-cells, macrophages or neutrophils in humans or animals in response to chemical and/or biological agents that activate these cell types. Measurements are made either in vivo (eg in mice) or in an in vitro preparation of human T-cells, macrophages or neutrophils, or a cell line derived therefrom. The substance is, in particular, emu oil or an ethanolic extract thereof. Therapeutic compositions and methods are also disclosed.
    本发明提供了一种确定化合物是否具有抗炎活性的新型科学方法。特别是,本发明的新型检测方法可以筛选出用于预防和治疗哺乳动物 T 细胞、巨噬细胞或中性粒细胞介导的疾病或改善其症状的化合物。特别是,本发明是基于对油或脂肪、油或脂肪的醇提取物、油或脂肪的生物活性成分或包含油或脂肪的制剂等物质的能力进行测定,以抑制人或动物体内的 T 细胞、巨噬细胞或中性粒细胞对激活这些细胞类型的化学和/或生物制剂的活性。测量可在体内(如小鼠体内)或体外制备的人类 T 细胞、巨噬细胞或中性粒细胞或由其衍生的细胞系中进行。该物质尤其是鸸鹋油或其乙醇提取物。还公开了治疗组合物和方法。
  • Marine sterols. VII. Synthesis of patinosterol, a minor constituent of sterols of the scallop, Patinopecten yessoensis
    作者:Kobayashi Masaru、Minamizawa Takao、Mitsuhashi Hiroshi
    DOI:10.1016/0039-128x(77)90124-6
    日期:1977.6
    The structure of patinosterol, a minor sterol from the scallop, Patinopecten yessoensis, was established as 22-trans-27-nor-(24S)-24-methyl-5alpha-cholest-22-en-3beta-ol by synthesis through Wittig reaction.
  • THERAPEUTIC PROPERTIES OF OILS
    申请人:WOMEN'S AND CHILDREN'S HOSPITAL
    公开号:EP1481243A1
    公开(公告)日:2004-12-01
  • [EN] THERAPEUTIC PROPERTIES OF OILS<br/>[FR] PROPRIETES THERAPEUTIQUES D'HUILES
    申请人:WOMENS & CHILDRENS HOSPITAL
    公开号:WO2003075003A1
    公开(公告)日:2003-09-12
    The present invention provides a novel scientific approach to determine whether a compound has anti-inflammatory activity. In particular, the novel assays allow the screening of compounds for the purposes of prophylactic and therapeutic use in treating or ameliorating the symptoms of T-cell, macrophage or neutrophil mediated diseases in mammals. In particular, the invention is based on the measurement of the capacity of a substance being an oil or fat, an alcoholic extract of an oil or fat, a biologically active component of an oil or a fat, or a preparation comprising an oil or fat, to suppress the activity of T-cells, macrophages or neutrophils in humans or animals in response to chemical and/or biological agents that activate these cell types. Measurements are made either in vivo (eg in mice) or in an in vitro preparation of human T-cells, macrophages or neutrophils or a cell line derived therefrom. The substance is, in particular, emu oil or an ethanolic extract thereof. Therapeutic compositions and methods are also disclosed.
  • Stereoselective synthesis via Claisen rearrangements of the marine sterols occelasterol, patinosterol, and 22,23-dihydrooccelasterol
    作者:Yutaka Hirano、Carl Djerassi
    DOI:10.1021/jo00133a036
    日期:1982.6
查看更多